Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Back to Industry News
Medtech

Reuters: US appeals court revives $2.5 billion opioid lawsuit

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Reuters
TL;DR

A U.S. appeals court revived a $2.5 billion lawsuit against Cencora, McKesson Corp., and Cardinal Health, reversing a previous ruling. The suit alleges the distributors contributed to the opioid crisis in Cabell County and Huntington, West Virginia by supplying large quantities of opioids and failing to report suspicious orders.

Key takeaways

  • appeals court has reinstated a $2
  • 5 billion lawsuit against drug distributors Cencora, McKesson Corp
  • , and Cardinal Health, as reported by Reuters
A U.S. appeals court has reinstated a $2.5 billion lawsuit against drug distributors Cencora, McKesson Corp., and Cardinal Health, as reported by Reuters. The suit alleges the companies contributed to the opioid addiction crisis in Cabell County and the City of Huntington, West Virginia. The 4th U.S. Circuit Court of Appeals overturned a 2022 ruling that had sided with the distributors. The appeals court determined the lower court erred in concluding the companies did not create a "public nuisance" by supplying a substantial quantity of addictive opioids to local pharmacies. The case has been remanded for re-evaluation to determine the companies' potential liability for the costs of addiction treatment and prevention programs. The ruling highlighted allegations that the companies failed to report numerous "suspicious" large orders of opioids to the U.S. Drug Enforcement Administration.

Related Topics

opioidslawsuitdrug distributorsWest Virginiaappeals court

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original